Haematopoietic prolyl hydroxylase‐1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis
Sophie Van Welden(Ghent University Hospital), Pieter Hindryckx(Ghent University Hospital), Martine De Vos(Erasmus MC), Ben Wielockx(Technische Universität Dresden), Filip De Vos(University Medical Center Utrecht), Benedicte Descamps(Ghent University), Lindsey Devisscher(Ghent University Hospital), Sarah Devriese(Ghent University Hospital), Georg Breier(University Hospital Carl Gustav Carus), Peter Carmeliet(Khalifa University of Science and Technology), Silvio Danese(IRCCS Ospedale San Raffaele), Simon J. Tavernier(Ghent University Hospital), Christian Vanhove(Ghent University Hospital), Sophie Janssens(Ghent University Hospital), Debby Laukens(Ghent University Hospital), Tom Holvoet(Ghent University Hospital), Ann Baeyens(Ghent University Hospital), Bart N. Lambrecht(Ghent University Hospital), Silvia D’Alessio(Humanitas University), Mélissa Dullaers(Sanofi (Belgium)), Carmen Correale(Humanitas University), Dirk Elewaut(Ghent University), Lien Van den Bossche(Unknown), Sara Neyt(Ghent University Hospital), Bruno Verhasselt(Ghent University Hospital)
Cited by 36
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k